Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review
The use of chimeric antigen receptor-T (CAR-T) cells have revolutionized the therapeutic paradigm of patients with lymphoid malignancies. However, infectious complications represent a frequent CAR-T cell-related adverse event, potentially being a major hurdle for the successful outcome of the patien...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2026-06-01
|
| Serija: | Frontiers in Medicine |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1830105/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|